Common solvent linked to liver cancer risk
By Kathryn Doyle NEW YORK (Reuters Health) - Scandinavian workers exposed to a common industrial cleaning fluid showed higher risk f...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Scandinavian workers exposed to a common industrial cleaning fluid showed higher risk f...
Read More »By Sharon Begley NEW YORK (Reuters) - The nation's largest experiment in delivering medical care in an innovative way has reduced co...
Read More »(Reuters) - Specialty pharmaceutical company Alliance Pharma Plc said it bought all existing rights to obstetric drug Syntometrine f...
Read More »By Zeba Siddiqui and Vrinda Manocha (Reuters) - Endo Health Solutions Inc said it plans to cut about 15 percent of its workforce and...
Read More »NEW YORK (Reuters) - A 10-year-old girl with cystic fibrosis who had been kept off an adult organ transplant list due to an age rest...
Read More »By Gene Emery NEW YORK (Reuters Health) - Group therapy works better than individual support for women in low-income countries who h...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite reminders, people scheduled for a colonoscopy didn't access an Internet vide...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - People age 75 and older are more likely than younger patients to wait longer than th...
Read More »By Jonathan Stempel NEW YORK (Reuters) - A U.S. appeals court on Wednesday said that some emergency contraception pills now can be s...
Read More »(Reuters) - Celgene Corp said on Wednesday that its flagship blood cancer drug, Revlimid, was approved by U.S. health regulators to ...
Read More »